The companies are:
- Allied Medical Supply Inc, which has offered cytarabine, used to treat leukaemia in children and adults, for over $990 per vial, more than 80 times a typical contract price of about $12 per vial;
- Superior Medical Supply Inc, which offered paclitaxel, used in the treatment of breast and ovarian cancers, for over $500 a vial, more than seven times a typical contract prices of around $65 per vial. Rep Cummings also notes that the California Attorney General filed a case alleging that the company "purchased, traded, sold or transferred dangerous drugs they knew, or reasonably should have known, were misbranded," and that it "disseminated false, misleading or deceptive statements, claims or images via the Internet, to induce the rendering of professional services or furnishing of products;"
- Premium Health Services Inc, which offered leucovorin, used in combination with the chemotherapy drug fluorouracil to treat advanced colon cancer, for over $270 per vial, more than 50 times a typical contract price of approximately $5 per vial;
- PRN Pharmaceuticals, which offered fluorouracil, used to treat colon, stomach, breast and pancreatic cancers, for over $350 a vial, more than 23 times a typical contract price of around $15 per vial; and
- Reliance Wholesale Inc, which offered magnesium sulfate, used to control life-threatening seizures in pregnant women and to treat magnesium deficiency in patients who are receiving intravenous feeding, for over $400 for 25 vials. This is more than 40 times a typical contract price of approximately $9 for 25 vials.